Literature DB >> 28131326

Clostridium difficile colitis: A clinical review.

Gabie K B Ong1, Tobi J Reidy2, Matthew D Huk2, Frederick R Lane3.   

Abstract

BACKGROUND: Clostridium difficile colitis is an important cause of morbidity and mortality in the surgical patient. In recent years, Clostridium difficile infections have shown marked increases in frequency, severity, and resistance to standard treatment. With urgent operative interventions and novel endoscopic approaches, pseudomembranous colitis is being seen more commonly in surgical practices. DATA SOURCES: In this paper, we will review a number of papers from the literature. We will discuss the epidemiology, evaluation and treatment of Clostridium difficile infection. Fulminant colitis may require emergency operation. For the surgical endoscopist, fecal microbiota transplantation restores the gastrointestinal flora, and has been shown to be effective in more than 80% of patients.
CONCLUSION: Clostridium difficile infection is a major cause of healthcare-related diarrhea leading to increased morbidity and mortality in surgical patients. Increases in failure rates and resistance to current treatments are clinical and economic challenges in the healthcare situation.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibiotic-associated diarrhea; Clostridium difficile colitis; Clostridium difficile infection; Diarrhea; Fecal microbiota transplantation; Inflammatory bowel disease; Pseudomembranous colitis

Mesh:

Substances:

Year:  2017        PMID: 28131326     DOI: 10.1016/j.amjsurg.2016.10.035

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  12 in total

1.  Faecal microbiota transplant decreases mortality in severe and fulminant Clostridioides difficile infection in critically ill patients.

Authors:  Emily N Tixier; Elijah Verheyen; Ryan C Ungaro; Ari M Grinspan
Journal:  Aliment Pharmacol Ther       Date:  2019-10-14       Impact factor: 8.171

2.  Role of the global regulator Rex in control of NAD+ -regeneration in Clostridioides (Clostridium) difficile.

Authors:  Laurent Bouillaut; Thomas Dubois; Michael B Francis; Nadine Daou; Marc Monot; Joseph A Sorg; Abraham L Sonenshein; Bruno Dupuy
Journal:  Mol Microbiol       Date:  2019-04-02       Impact factor: 3.501

3.  DdlR, an essential transcriptional regulator of peptidoglycan biosynthesis in Clostridioides difficile.

Authors:  Laurent Bouillaut; William Newton; Abraham L Sonenshein; Boris R Belitsky
Journal:  Mol Microbiol       Date:  2019-09-13       Impact factor: 3.501

4.  The molecular structure of the glycoside hydrolase domain of Cwp19 from Clostridium difficile.

Authors:  William J Bradshaw; Jonathan M Kirby; April K Roberts; Clifford C Shone; K Ravi Acharya
Journal:  FEBS J       Date:  2017-11-17       Impact factor: 5.542

Review 5.  The structure of the S-layer of Clostridium difficile.

Authors:  William J Bradshaw; April K Roberts; Clifford C Shone; K Ravi Acharya
Journal:  J Cell Commun Signal       Date:  2017-11-23       Impact factor: 5.782

6.  Pathogenicity locus determinants and toxinotyping of Clostridioides difficile isolates recovered from Iranian patients.

Authors:  A Aliramezani; M Talebi; A Baghani; M Hajabdolbaghi; M Salehi; A Abdollahi; S Afhami; M Marjani; F Golbabaei; M A Boroumand; A Sarrafnejad; M Yaseri; S Ghourchian; M Douraghi
Journal:  New Microbes New Infect       Date:  2018-08-02

7.  Risk factors and outcomes of Clostridium difficile infection in hospitalized patients.

Authors:  Hao-Yuan Lee; Hsuan-Ling Hsiao; Chin-Yuan Chia; Chun-Wen Cheng; Tzu-Cheng Tsai; Shin-Tarng Deng; Chyi-Liang Chen; Cheng-Hsun Chiu
Journal:  Biomed J       Date:  2019-05-07       Impact factor: 4.910

8.  A Two-Step Approach for Diagnosing Glutamate Dehydrogenase Genes by Conventional Polymerase Chain Reaction from Clostridium difficile Isolates.

Authors:  Sepideh Khodaparast; Ashraf Mohabati Mobarez; Mehdi Saberifiroozi
Journal:  Middle East J Dig Dis       Date:  2019-05-15

9.  Cwp2 from Clostridium difficile exhibits an extended three domain fold and cell adhesion in vitro.

Authors:  William J Bradshaw; Jonathan M Kirby; April K Roberts; Clifford C Shone; K Ravi Acharya
Journal:  FEBS J       Date:  2017-07-23       Impact factor: 5.542

10.  Clinical impact of a Clostridioides (Clostridium) difficile bedside infectious disease stewardship intervention.

Authors:  María Olmedo; Maricela Valerio; Elena Reigadas; Mercedes Marín; Luis Alcalá; Patricia Muñoz; Emilio Bouza
Journal:  JAC Antimicrob Resist       Date:  2020-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.